Novalgin (Metamizole Sodium Monohydrate)

Metamizole Sodium exerts its effect by non‑selectively inhibiting cyclooxygenase enzymes, which reduces the synthesis of prostaglandins involved in pain signaling and fever generation. Additionally, it has central analgesic activity and a spasmolytic effect that helps relieve visceral pain.

The dosage of Novalgin is determined by the prescribing physician based on the patient’s condition, age, weight, and response to therapy. The prescriber will select the appropriate strength, frequency, and duration in accordance with local clinical guidelines and regulatory requirements.

Safety of Metamizole Sodium in pregnancy and lactation has not been definitively established. It should only be used if the potential benefit justifies the potential risk to the fetus or infant, and the decision must be made by a qualified healthcare professional after careful assessment.

To place an order, submit an enquiry on the Novalgin product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements), and necessary import documentation.

Compared with traditional NSAIDs, Metamizole Sodium offers potent analgesic and antipyretic effects with a lower incidence of gastrointestinal irritation, but it carries a unique risk of agranulocytosis. Unlike opioids, it does not produce significant respiratory depression, making it a useful alternative for certain pain indications when monitored appropriately.

Novalgin should be stored at ambient temperature, below 25 °C, in its original packaging to protect it from moisture and light. Keep the product out of reach of children and avoid storing it in areas with high humidity or temperature fluctuations.

Novalgin is administered orally, typically as a tablet or oral solution, and should be taken with or without food as directed by the prescriber. The exact method of administration, including whether to swallow whole or dissolve, depends on the specific dosage form supplied.

The most serious adverse reactions include agranulocytosis, which can lead to severe infections, and life‑threatening allergic responses such as anaphylaxis. Patients should be monitored for signs of infection, unexplained fever, sore throat, or skin reactions, and immediate medical attention is required if these occur.

Novalgin should be avoided in individuals with known hypersensitivity to Metamizole or other pyrazolones, in patients with pre‑existing severe blood dyscrasias, and in those for whom safer alternatives are available, such as pregnant women unless absolutely necessary. It is also contraindicated in children unless specifically prescribed by a specialist.